Skip to content
naulon

Not checkedNot checked for notices yet.

An analysis of COVID-19 vaccine sentiments and opinions on Twitter

Samira Yousefinaghani, Rozita Dara, Samira Mubareka and 2 more

International Journal of Infectious Diseases · 2021

doi:10.1016/j.ijid.2021.05.059 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Objective: We identified public sentiments and opinions toward the COVID-19 vaccines based on the content of Twitter. Materials and methods: We retrieved 4,552,652 publicly available tweets posted within the timeline of January 2020 to January 2021. Following extraction, we identified vaccine sentiments and opinions of tweets and compared their progression by time, geographical distribution, main themes, keywords, posts engagement metrics and accounts characteristics. Results: We found a slight difference in the prevalence of positive and negative sentiments, with positive being the dominant polarity and having higher engagements. The amount of discussion on vaccine rejection and hesitancy was more than interest in vaccines during the course of the study, but the pattern was different in various countries. We found the accounts producing vaccine opposition content were partly Twitter bots or political activists while well-known individuals and organizations generated the content in favour of vaccination. Conclusion: Understanding sentiments and opinions toward vaccination using Twitter may help public health agencies to increase positive messaging and eliminate opposing messages in order to enhance vaccine uptake.

Abstract licence: CC BY-NC-ND

References38

  1. 20.
  2. 21.
  3. 29.
  4. 31.

34 more references, whose wording the paper’s licence keeps private.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.